More Great News!!!
Innovus Pharma Signs Purchase Agreement with CVS Pharmacy, Inc. to Sell Its Product Androferti® to Increase Sperm Quality in Their Newly Established In-Store Men’s Clinic
CVS Men’s Health Clinic Pilot Program to Promote Androferti® in 12 to 20 Stores with the Potential, if Successful, to Expand Nationwide and Add Additional Products
July 19, 2018 06:05 AM Eastern Daylight Time
SAN DIEGO--(BUSINESS WIRE)--Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women’s health and respiratory diseases, today announced that it has entered into a pilot program with the nationwide pharmaceutical chain CVS Pharmacy, Inc. (“CVS”), which is a subsidiary of CVS Health Corp (NYSE: CVS), to sell the Company’s product Androferti®, to increase sperm quality. If successful, the CVS pilot program could lead to the national pharmacy stocking and selling Androferti® on a scalable level nationwide and could expand to add additional Innovus Pharma products.
“In addition, we are in discussion to potentially add more product under this program.”
Tweet this
“We are very pleased to have been chosen by CVS to be part of their newly established in-store men’s health clinic,” said Dr. Bassam Damaj, the President and Chief Executive Officer of Innovus Pharma. “In addition, we are in discussion to potentially add more product under this program.”
About Androferti
Androferti®, is a patented dietary supplement shown in multiple published clinical trials to statistically increase seminal quality (concentration, motility, morphology and vitality) and enhance spermatozoa quality (decreases of vacuoles in the sperm nucleus, decreases DNA fragmentation, decreases the dynamics of sperm DNA fragmentation, and improvement on the inventory of mobile sperm (“REM”)).
The Company believes that Androferti® is the only product clinically proven in multiple published clinical trials to increase the Sperm Quality and enhance Spermatozoa Quality as compared to other products where the claims are based primarily on an ingredient used in the products.
According to reports by IBIS World in August 2014, the fertility market is estimated to be around $2 billion with a 2.5% annual increase. There are currently 682 In-Vitro Fertility (IVF) clinics in the U.S. Androferti® is currently available directly to IVF clinics and online at www.myandroferti.com at a price of $95 per box, which is sufficient for a one month supply. For optimal results from the published clinical trials optimal results of Androferti® are observed with 3 months of continuous use.
About Innovus Pharmaceuticals, Inc.
AI
